Superiority of Rocuronium Reversed with Sugammadex for Overweight and Obese Patients Anesthesia: A Randomized Controlled Trial
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 12 Apr 2018
At a glance
- Drugs Rocuronium bromide (Primary) ; Sugammadex (Primary) ; Cisatracurium besilate; Neostigmine
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 12 Apr 2018 Planned End Date changed from 1 Apr 2019 to 1 Jul 2020.
- 12 Apr 2018 Planned initiation date changed to 1 Jul 2018.
- 05 Mar 2018 New trial record